key: cord-1021965-lri89p33
authors: Vranis, Neil M.; Bekisz, Jonathan M.; Daar, David A.; Chiu, Ernest S.; Wilson, Stelios C.
title: Clinical outcomes of COVID-19 positive patients who underwent surgery: A New York City experience
date: 2020-11-23
journal: J Surg Res
DOI: 10.1016/j.jss.2020.10.032
sha: 2919a5085b0784eb6e9cbd8d19d4bb5cc40a1372
doc_id: 1021965
cord_uid: lri89p33

BACKGROUND: The COVID-19 global pandemic has led to a halt in elective surgeries throughout the United States and many other countries throughout the world. Early reports suggest that COVID-19 patients undergoing surgery have an increased risk of requiring ICU admission and overall mortality. MATERIALS AND METHODS: A retrospective review was performed of all COVID-19, positive with PCR confirmation, patients who had surgery between February 17, 2020 and April 26, 2020 at a major New York City hospital. Clinical characteristics and outcomes including ICU admission, ventilator requirement, and mortality were analyzed. RESULTS: Thirty-nine COVID-19 surgical patients were identified. Mean age was 53.9 years and there were more males than females in the cohort (56.4% vs 43.6%). Twenty-two patients (56.4%) had a confirmed positive COVID-19 test pre-operatively and the remainder tested positive after their procedure. The majority (59%) of patients had an American Society of Anesthesiologists (ASA) class of 3 or higher. Post-operatively, 7 patients (17.9%) required ICU level care with a mean length of stay of 7.7 days. There were 4 deaths (10.3%) in this patient population, all of which occurred in patients who were ASA Class 3 or 4. CONCLUSIONS: This study represents the largest study to date, that objectively analyzes the outcomes of COVID-19 positive patients who underwent surgery. Overall, ICU admission rates and mortality are similar to reported rates in the literature for non-surgical COVID-19 patients. Notably, in COVID-19 patients with ASA 1 or 2, there was a 0% mortality rate in the post-operative period.

The 2019 novel coronavirus disease , caused by the SARS coronavirus 2 (SARS-CoV-2), has evolved from an outbreak in Wuhan, China to a worldwide pandemic. [1] [2] [3] In response, many countries have instituted various international travel restrictions, post-exposure quarantine protocols and community social distancing guidelines, as well as other public health measures to protect citizens and offset the pressures of overburdened healthcare systems. 4, 5 In the United States, the Surgeon General put a pause on all elective or non-emergent surgery in an attempt to aid in the conservation of resources, minimize unnecessary exposures, and help slow the spread of disease. 6 Early reports show that the majority of patients infected with SARS-CoV-2 remain asymptomatic or have only mild symptoms. In contrast, a smaller, but striking, percentage of individuals develop severe respiratory compromise that can rapidly deteriorate to acute respiratory distress syndrome (ARDS) and even multi-system organ failure (MOF). 1 Reported symptoms include fever, cough, sore throat, headache, fatigue, dyspnea, malaise, diarrhea, arthralgias or myalgias which will typically present within 14 days of infectivity. 1, 2, 7 However, reports of longer "incubation periods", up to 24 days, have been cited in the literature. 8 Prior studies suggest an increased risk of mortality for COVID-19 positive patients who undergo surgery. The earliest report from Iran describes three patients who had routine intraabdominal procedures during the presumed viral incubation period, two of whom died from ARDS and MOF. The third patient had an extended hospital course but ultimately recovered from their respiratory symptoms and was discharged home. 9 More recently, a study published J o u r n a l P r e -p r o o f from Wuhan, China, analyzed 34 asymptomatic patients who underwent surgery during the incubation period of COVID-19. 10 The group found that 44% of the patients were admitted to the intensive care unit (ICU) with a 20.5% mortality rate. 10 These findings prompted the authors to suggest that undergoing surgery during the incubation period may contribute to the high rate of ICU admission and mortality. However, they acknowledge that procedural complexity and having multiple co-morbidities were associated with a worse prognosis. Theories to explain the observed trends include ventilator associated barotrauma, hypercoagulable state from the COVID-19 disease process and/or anesthesia, a systemic cytokine response secondary to surgical insult, or even the mere additional exposures to nosocomial COVID-19 strains and other infectious organisms. 5, 8, [11] [12] [13] As the number of confirmed cases, hospital admissions, and the volume of COVID-19 associated mortality decline, restrictions for performing elective surgeries are expected to be lifted. Understanding the virus, disease process, and complications that can arise from operating on patients with active COVID-19 or asymptomatic patients during the incubation period will help guide best practices during these uncertain times. To that end, this study was designed to describe the surgical experience at a single institution, located in a large, densely populated urban area at the height of the COVID-19 pandemic, to help determine the effect of surgery, including the use of general anesthesia, on patients with COVID-19 or asymptomatic patients who subsequently tested positive for SAR-CoV-2.

J o u r n a l P r e -p r o o f After obtaining institutional review board approval (i20-00644) and a waiver of informed consent given the nature of the study, a retrospective review was performed of all patients who had surgery performed between March 6, 2020 and April 26, 2020 at Bellevue Hospital Center (New York, NY). It is the oldest public hospital in the United States and serves the most affected city in the world during the COVID-19 pandemic. This time period included the time leading up to the apex of COVID-19 positive cases in New York City, the apex, and the presumed decline.

Individuals were included for analysis if they had surgery and also found to be SARS-CoV-2 positive by nasopharyngeal swab polymerase chain reaction (PCR) up to 14 days preoperatively or 24 days postoperatively. For the purpose of this study, patients who had a bedside surgical procedure directly related to COVID-19 sequelae and care, including but not limited to tracheostomy tube placement, gastrostomy tube placement and insertion of peritoneal dialysis catheters, were excluded from study. Patients were also excluded if their surgery was performed for COVID-19-related infection or other sequelae.

All patients required a documented positive COVID-19 test. Testing related to this study was performed by PCR confirmation through the Bellevue Hospital laboratory and approved outside vendors using nasopharyngeal swab samples. The two primary tests utilized were the COVID-19 RT-PCR assay developed by BioReference Laboratories (Bio-Reference Laboratories, Inc., Elmwood Park, NJ) for which information related to sensitivity and specificity is not yet available, and the Cepheid Xpert® Xpress SARS-CoV-2rapid test (Cepheid Inc, Sunnyvale, CA), reported to have a sensitivity of 95% and a specificity of 100%. 14 J o u r n a l P r e -p r o o f Demographic data, patient comorbidities, and procedural information were collected.

Surgical outcomes including operative details, escalation to intensive care unit (ICU) level care, or need for prolonged post-operative ventilation were recorded. Dates of symptoms onset, emergency room visits, surgery and hospital admission and discharge were systematically captured. Patients were classified by the American Society of Anesthesiologists (ASA) Physical Status pre-surgical classification. 15 (Figure 1 )

Statistical analysis was performed using SPSS statistical software package, version 25 (IBM®, Armonk, NY). Descriptive statistics and frequencies were calculated for the entire patient population and each subgroup analyzed. For comparisons between groups, the appropriate parametric or non-parametric tests were conducted based on the nature of variable and included the Student's t-test, the Mann-Whitney U test, and the chi-squared or Fischer's exact test. For the purpose of two-tailed univariate analysis, the cutoff for statistical significance was set at an alpha (α) of 0.05.

A total of 39 PCR confirmed COVID-19 symptomatic patients underwent a surgical procedure at Bellevue Hospital Center from March 6, 2020 through April 26, 2020. The mean age was 53.9 years (Range 9-91 years) and there was a predominance of male patients in the cohort, with 22 men (56.4%) compared to 17 women (43.6%). Many racial and ethnic backgrounds were represented, however, nearly half were identified as having Hispanic or Latin J o u r n a l P r e -p r o o f ethnicity (46.2%). The majority (71.8%) were domiciled in a house or an apartment; the remainder were either homeless or shelter-domiciled (15.4%), resided in a long-term care facility (7.7%) or were incarcerated in the New York City correctional system (5.1%). (Table 1 )

With respect to the general health of this patient cohort prior to COVID-19 infection, mean body mass index (BMI) was 26.89. Nearly a quarter had a history of current or prior tobacco use (8.8% active, 14.7% former). Hypertension was the most common comorbidity, present in 18 patients (46.2%), followed by coronary artery disease, COPD, and chronic kidney disease in 5 patients (12.8%) each. 4 individuals (10.3%) had renal failure at baseline and were on hemodialysis prior to the COVID-19 pandemic. (Table 1 )

Among these 39 patients, 22 (56.4%) had a confirmed positive COVID-19 test prior to surgery. 3 individuals required hospital admission for treatment of their COVID-19 infection pre-operatively with 1 needing escalation to the intensive care unit (ICU). For those patients with an unknown viral status pre-operatively, the mean number of days between a SARS-CoV-2 positive test result and surgery was 5.6 (Range 0-33). It must be noted that the individual who initially tested positive more than 30 days out from surgery had a repeat positive test 2 days prior to being taken to the operating room. For patients whose viral testing was done subsequently to surgery, testing occurred an average of 12.88 days (Range 0-24) following their procedure.

( Table 1) J o u r n a l P r e -p r o o f Twenty patients (51.3%) had documented evidence of at least one COVID-19 symptom in the pre-operative period. Cough and objective fever were the most commonly cited (n=10, 25.6%) followed by shortness of breath in 5 individuals (12.8%). Symptoms began an average of 14 days (Range 1-22) prior to surgery. (Table 1 )

These 39 patients underwent a total of 42 procedures in the operating room over the duration of this study. For the purposes of statistical analysis, only the primary procedure to address their underlying problem was included (e.g., an initial amputation was selected over subsequent revision or debridement). Nearly all cases were performed for emergent or urgent indications. General Surgery and Orthopedic/Hand Surgery were responsible for treating the largest percentages of these patients (n=8, 20.5%), followed by Neurosurgery, Vascular Surgery, and Cardiothoracic Surgery/Interventional Cardiology (n=4, 10.7%). (Table 2) Mean procedure length was approximately 177.3 minutes and nearly 90% of patients received general anesthesia (n=35) with endotracheal intubation (n=34). The American Society of Anesthesiologists (ASA) class was 3 or higher in 59% of the population, including 8 (20.5%) patients meeting criteria for Class 4. ( Table 2 ).

The anesthesiologists were unable to extubate 3 patients (7.7%) at the immediate conclusion of the procedure, secondary to difficulty weaning oxygen and ventilatory support requirements in 2 individuals and the presence of a hemopneumothorax in another, while 7 (17.9%) patients were found to have COVID-related ICU needs that had not been present pre- Table 2) Severe complications of COVID-19 developed in 10 patients (25.6%). Shock requiring pharmacologic blood pressure support and acute kidney injury were the most common, occurring in 6 individuals each (15.4%). ARDS and secondary infection were also seen in 5 patients each.

One patient suffered from a vaso-occlusive complication in the form of acute lower extremity ischemia secondary to an undetermined but likely embolic or in situ thrombotic etiology. (Table   2) At the time of manuscript submission, 9 patients (23.1%) remain admitted to the hospital, while 26 (66.7%) have been discharged home or to rehabilitation facilities. ( Table 2 (Table 3 ) Each death occurred at least a week after surgery, and 75% were in patients who had been admitted to the ICU, with the date of ICU admission coming a minimum of 12 days post-operatively. The causes of death have only been determined for 2 of these individuals (multi-organ system failure, secondary to cardiac arrest). (Table 3 )

Patients were grouped according to low (1 or 2) or high (3 or 4) ASA class and compared on the basis of demographics, health history, COVID-19 infection course, and surgical outcomes.

( Table 4 ) There were 16 patients in the low ASA class group and 23 in the high ASA Class group. Those in the low ASA class group tended to be younger (mean age 46.5 vs 59.1 years, p=0.056) and have lower mean BMI 24.75 vs 28.35, p=0.193), though neither comparison yielded statistical significance. Patients in the high ASA class group had significantly higher rates of hypertension (60.9% vs 25%, p=0.049) while the rates of coronary artery disease, COPD, and chronic kidney disease were not significant. There was no discernible difference in the rates patients experienced pre-operative COVID-19 symptoms (Low ASA=50% vs High ASA=52.2%, p=0.894). Patients in the low ASA class group more frequently had a known positive COVID-19 test prior to surgery (75% vs 43.5%, p=0.099) but this difference was not statistically significant.

Regarding post-operative outcomes, no statistically significant differences were detected with respect to a new COVID-related need for ICU management (Low ASA=12.5% vs High ASA=21.7%, p=0.678) or ICU length of stay (Low ASA=6 days vs High ASA=8.1 days, p=0.667). However, patients in the low ASA class group had significantly shorter durations of J o u r n a l P r e -p r o o f their overall hospital length of stay, with a mean of 6.6 days compared to 30.8 days (p=0.008).

Finally, there was a 17.4% mortality rate (n=4) in the high ASA class group, compared to zero deaths in the low ASA class group (p=0.130).

To better understand mortality in the post-operative patient with COVID-19, the patient population was divided on the basis of whether or not they remained alive at the time of manuscript submission (n=35) or were deceased (n=4). Patients who ultimately died were on average older (65.5 vs 52.6 years, p=0.195) and had lower BMIs (21.3 vs 27.6, p=0.103) though neither of these comparisons reached statistical significance. They had higher rates of every comorbidity with the exception of diabetes mellitus and a history of cerebrovascular accident, and these rates were statistically significantly different with respect to COPD (75% vs 5.7%, p=0.004), chronic kidney disease (75% vs 5.7%, p=0.004), and being hemodialysis-dependent (50% vs 5.7%, p=0.045). It bears noting that none of the deceased patients were known to be COVID-19 positive pre-operatively, compared to 62.9% of those who remain alive (p=0.029).

( Table 5) The cohort of survivors was then further stratified to include only those with ASA Class 3 or 4 status. A significant difference in BMI was identified, as those who remained alive were had a mean BMI 8 points higher than the deceased (29.9 vs 21.3, p=0.042). Additionally, patients that died had significantly higher rates of COPD (75% vs 10.5%, p=0.021) and chronic kidney disease (75% vs 10.5%, p=0.021). (Table 5) J o u r n a l P r e -p r o o f Currently, studies in the literature associating COVID-19 and increased surgical risk with poorer outcomes are limited to small case reports or make generalized conclusions that are not supported by the data. Recently, a multi-hospital study from Wuhan China reported 20% mortality rate in 34 patients. 10 However, it lacks a comparison group and the majority of the patients who died had multiple co-morbidities or underwent index procedures that involved thoracic surgery, suggesting that many of these patients had some degree of respiratory compromise at baseline. Publishing this data during these challenging times on a novel virus is quite valuable. However, generalized conclusions regarding COVID-19 and its associated J o u r n a l P r e -p r o o f perioperative risk for otherwise healthy patients that fall in the ASA 1 or 2 category should not be made based off such studies alone. In our cohort of patients who underwent surgery, all of the patients in the ASA 1 or 2 class have survived. In a recent meta-analysis of over 650 patients, the authors found that 20% of hospitalized, infected COVID-19 patients required an ICU admission and 14% of the hospital patients had fatal outcomes. 7 Our data, composed of surgical patients (18% ICU admission rate, 10% mortality), aligns with the results these authors present, suggesting that patients undergoing surgery do not appear to have a significantly increased risk of mortality.

Each surgical sub-specialty has a cohort of medically indicated, high priority procedures that are not considered emergent. For the months during which the COVID-19 was at its peak in New York City, these procedures were either discouraged or prohibited by hospital institutions.

With limited understanding of the surgical and/or anesthetic impact on the physiology of those infected with SARS-CoV-2, this can be challenging for surgeons, patients, and their families. 17 During these times of uncertainty, there is a moral and ethical obligation for surgeons to remain current on the evolving literature and best practices. It is imperative healthcare providers clearly convey the risks associated with each procedure while acknowledging the potential for additional contributing factors such as COVID-19 that may alter the risk profile for that procedure or the subsequent post-operative care. Conversely though, the timeline of societal recovery from this pandemic is uncertain, and many anticipate that the slow return to "normal" may take several more months. During this time period, the potential repercussions from improper, generalized cancelation or delay of all non-emergent surgeries may yield significant pain, distress and J o u r n a l P r e -p r o o f morbidity for patients and society. 6 Therefore, careful consideration, risk stratification, and preoperative patient counseling are imperative as bans lift on elective surgery.

As with all studies, this study has its limitations. First, it is a retrospective review from a single hospital. However, given the severity of this pandemic and the rapidly evolving healthcare regulations regarding elective surgery, the authors believe that publishing these results adds value to the medical community as we begin to evaluate the future of elective surgery in the near-term. While many patients in our cohort were confirmed SARS-CoV-2 positive prior to surgery, there were several patients in the early part of this study, when testing kits were unavailable or their use was not widespread, that were presumed to be in the incubation period based on the estimated time from the day they subsequently tested positive for the virus on PCRbased testing. We included all patients that tested positive up to 14 days prior to their surgery or up to 24 days after their surgery, based on the longest incubation time that has been reported to date in an effort to ensure that we captured all infected patients that underwent surgery at our institution. 8 patients is presumed to be attributed to COVID-19. One patient, a 65-year-old SARS-Cov-2 positive, drug dependent, active smoker was diagnosed with pyogenic arthritis, underwent knee wound irrigation and debridement, and expired unexpectantly 8 days after surgery while recovering on the floor. Patients with severe COVID-19 illness have a propensity for a hypercoagulable state, however, an autopsy could not be performed. Although he had tested positive for SARS-CoV-2, he remained asymptomatic during his hospitalization and was only tested because his roommate had been found to be positive for COVID-19. Further, this patient received none of the treatments being used at that time to combat the virus, including hydroxychloroquine, tocilizumab, or corticosteroids, and thus the true cause of death remains unknown. We included this patient in the analysis, despite significant contemplation that the J o u r n a l P r e -p r o o f cause of death was unrelated to COVID-19, which would only strengthen our findings and conclusions. While this study would indeed be strengthened by comparing this COVID positive cohort to a matched control of patients undergoing surgery who were COVID negative, we are limited by the study period (a <2 month duration) and single-institution setting. This prevented our ability to obtain a properly matched cohort of control patients with similar patient and operative characteristics. Nevertheless, our case series is valuable in its size and timeliness as we continue to battle the COVID-19 pandemic today.

We have critically analyzed the hospitalizations and post-operative outcomes for 39 PCR-confirmed SARS-Cov-2 patients that underwent surgery during the apex of the COVID-19 epidemic in a large volume New York City hospital. The rate of ICU admission and mortality of these patients appears to be similar to non-surgical COVID-19 patients that have been reported in the literature. It was encouraging to find that none of the patients with ASA 1 or 2 scores died in the immediate post-operative period. These findings support the risk stratification of elective surgery algorithms that Dr. Stahel presents in his recent editorial. 6 We encourage all researchers to work together and continue accruing objective data so that healthcare professionals and hospitals are better able to risk stratify COVID-19 positive surgical candidate patients to achieve safe clinical outcomes. Table 1 . Demographics, baseline co-morbid medical conditions, pre-operative course of COVID-19 infection, and disease management in all patients included in the study. Table 2 . Details of surgical procedures performed on patients within the study population, including surgical service responsible for the care of the patient, intra-operative anesthesia and airway management, as well as post-operative outcomes and ultimate disposition. Table 3 . In-depth details of the demographics, baseline health, pre-and/or post-operative COVID-19 disease course, and clinical outcomes in the patients (n=4) who expired during the post-operative period. Table 4 . Comparison of baseline demographics and characteristics, COVID-19 disease course, and operative outcomes between patients with low (Class 1 or 2) and high (Class 3 or 4) American Society of Anesthesiologists Physical Status classes. 

Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-topositivity, and Potential Role of Chest CT-scan

SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options

Coronavirus Live Updates: W.H.O. Declares Pandemic as Number of Infected Countries Grows. The New York Times

We Asked the Experts: How Do We Maintain Surgical Quality Standards for Enhanced Recovery Programs After Cancer Surgery During the COVID-19 Outbreak?

Acute care surgery and postoperative COVID-19 pneumonia: a surgical and environmental challenge

How to risk-stratify elective surgery during the COVID-19 pandemic?

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Unexpected Fatality in Perioperative Period

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

Early Experience in Paris with the Impact of the Covid-19 Pandemic on Vascular Surgery

Thromboinflammation and the hypercoagulability of COVID-19

COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test

ASA Physical Status Classification System. 2019. 5/1/2020

Outbreak of Middle East Respiratory Syndrome-Coronavirus Causes High Fatality After Cardiac Operations

Unknown unknowns: Surgical consent during the COVID-19 pandemic

J o u r n a l P r e -p r o o f 

Highlights:• Patients infected with COVID-19 are not necessarily at higher risk of peri-operative mortality.• Those with low ASA class status (Ex: 1 and 2) had a 0% mortality rate in our cohort.• Peri-operative ICU admission rates were similar to those reported in patients without COVID-19.• Infection with COVID-19 should not be an absolute contraindication to necessary surgery.J o u r n a l P r e -p r o o f